0001704086-18-000001.txt : 20180103 0001704086-18-000001.hdr.sgml : 20180103 20180103153150 ACCESSION NUMBER: 0001704086-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180103 DATE AS OF CHANGE: 20180103 EFFECTIVENESS DATE: 20180103 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Expansion Therapeutics, Inc. CENTRAL INDEX KEY: 0001691275 IRS NUMBER: 814414709 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-302251 FILM NUMBER: 18504957 BUSINESS ADDRESS: STREET 1: 491 PINE NEEDLES DRIVE CITY: DEL MAR STATE: CA ZIP: 92014 BUSINESS PHONE: (650) 430-5836 MAIL ADDRESS: STREET 1: 491 PINE NEEDLES DRIVE CITY: DEL MAR STATE: CA ZIP: 92014 D 1 primary_doc.xml X0708 D LIVE 0001691275 Expansion Therapeutics, Inc. 491 PINE NEEDLES DRIVE DEL MAR CA CALIFORNIA 92014 (650) 430-5836 DELAWARE None None Corporation true 2016 Kevin Forrest, Ph.D. c/o Expansion Therapeutics, Inc. 491 Pine Needles Drive Del Mar CA CALIFORNIA 92014 Executive Officer Director Matthew Disney, Ph.D. c/o Expansion Therapeutics, Inc. 491 Pine Needles Drive Del Mar CA CALIFORNIA 92014 Director Scott Rocklage, Ph.D. c/o 5am Ventures 501 Second Street, Suite 350 San Francisco CA CALIFORNIA 94107 Director Jason Hafler, Ph.D. c/o Aventis Inc. 55 Corporate Drive Bridgewater NJ NEW JERSEY 08807 Director Yujiro Hata, M.B.A. c/o Expansion Therapeutics, Inc. 491 Pine Needles Drive Del Mar CA CALIFORNIA 92014 Director Beth Seidenberg, M.D. c/o KPCB Holdings Inc. 2750 Sand Hill Road Menlo Park CA CALIFORNIA 94025 Director Campbell Murray, M.B.B.S., M.B.A. c/o Novartis Venture Fund 100 Technology Square, Suite 5150 Cambridge MA MASSACHUSETTS 02139 Director Pharmaceuticals Decline to Disclose 06b false 2017-12-18 true true false 0 55305863 25305863 30000000 Total Offering Amount and Total Amount Sold includes amounts paid pursuant to conversion of indebtedness. false 8 0 0 0 false Expansion Therapeutics, Inc. /s/ Kevin Forrest Kevin Forrest, Ph.D. President and Chief Executive Officer 2017-12-22